Maze Therapeutics, Inc. Common Stock (MAZE) — Free Cash Flow Generation Index
Maze Therapeutics, Inc. Common Stock (MAZE) has a Free Cash Flow Generation Index of 1.00x as of June 2024. Free cash flow of $144.89 Million represents 1% of operating cash flow ($145.05 Million). Read Maze Therapeutics, Inc. Common Stock balance sheet liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Maze Therapeutics, Inc. Common Stock Free Cash Flow Generation Index (2024–2024)
Historical FCF Generation Index trend for Maze Therapeutics, Inc. Common Stock across 1 annual periods. Explore capital reinvestment ratio of Maze Therapeutics, Inc. Common Stock to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Maze Therapeutics, Inc. Common Stock (2024–2024)
Year-by-year Free Cash Flow Generation Index for Maze Therapeutics, Inc. Common Stock. For the full company profile including market capitalisation, see market value of Maze Therapeutics, Inc. Common Stock.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.98x | $74.81 Million | $75.95 Million | $1.15 Million | — |